CapsoVision (NASDAQ:CV) Shares Gap Down – Should You Sell?

Shares of CapsoVision, Inc. (NASDAQ:CV) gapped down prior to trading on Friday . The stock had previously closed at $12.39, but opened at $10.85. CapsoVision shares last traded at $11.05, with a volume of 7,782 shares.

Analyst Ratings Changes

A number of analysts recently commented on the company. Benchmark reiterated a “speculative buy” rating on shares of CapsoVision in a research report on Friday, November 14th. Roth Capital set a $7.00 price target on shares of CapsoVision in a research report on Tuesday, November 4th. Zacks Research raised shares of CapsoVision to a “hold” rating in a report on Wednesday, November 5th. Finally, Weiss Ratings restated a “sell (e)” rating on shares of CapsoVision in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $6.00.

CapsoVision Trading Up 1.9%

The firm has a 50-day moving average of $7.86.

CapsoVision (NASDAQ:CV) last issued its earnings results on Thursday, November 13th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.03). The company had revenue of $3.54 million during the quarter.

Institutional Trading of CapsoVision

An institutional investor recently bought a new position in CapsoVision stock. New York State Common Retirement Fund acquired a new position in CapsoVision, Inc. (NASDAQ:CV) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,114 shares of the company’s stock, valued at approximately $34,000.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.